Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis
Year: 2020
Type: article
Institutions: University of Michigan, NYU Langone Health, New York University, Children's Hospital at Montefiore, University of Minnesota, Children's National, George Washington University, Stony Brook University Hospital, Cleveland Clinic, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Goldfinch Bio (United States), Pfizer (United States), Michigan Medicine
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Tacrolimus vs Intensive Prednisone in Pediatric FSGS, Focal Glomerulosclerosis Trial Data Coordinating Center, Multicenter Trial of Focal Glomerulosclerosis, Michigan Institute for Clinical and Health Research (MCHR), Michigan Institute for Clinical and Health Research (MICHR), OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS, Nephrotic Syndrome Rare Disease Clinical Research Network III
OpenAlex ID: W3048143283
